Fresenius Kabi is the leader in infusion therapy and clinical nutrition in Europe and in its most important countries of Latin America and Asia Pacific. Within I.V. generic drugs, Fresenius Kabi counts among the leading suppliers in the U.S. market.
All over the world more than 24,000 employees are committed to improving the quality of life of critically and chronically ill patients with innovative products for patients in hospitals and outpatients.
Headquarters
Szepvolgyi ut 6. III. em.
Budapest; Budapest;
Postal Code: 1025
Contact Details: Purchase the Fresenius Kabi Hungary Kft. report to view the information.
Website: http://www.fresenius-kabi.hu
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service